Leaflet NAPROXEN AUROBINDO 250mg tablets


Indicated for: pain and inflammation

Route of administration: oral

Substance: naproxen (nonsteroidal anti-inflammatory drug)

ATC: M01AE02 (Musculo-skeletal system | Antiinflammatory and antirheumatic products, non-steroids | Propionic acid derivatives)

Precautions:
Photosensitivity
Photosensitivity

Avoid excessive exposure to sunlight or UV radiation.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Ulcer / gastrointestinal bleeding
Ulcer / gastrointestinal bleeding

This medicine may increase the risk of ulcer or gastrointestinal bleeding.


Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used to relieve pain, inflammation, and fever. It is especially recommended for conditions such as arthritis, muscle pain, back pain, menstrual cramps, or other types of moderate pain. Naproxen works by blocking substances in the body that cause inflammation and pain.

Naproxen is usually taken orally, in the form of tablets or capsules, and the dose is determined by the doctor based on age, weight, and the condition being treated. It is important not to exceed the recommended dose and to follow your doctor's instructions to avoid the risk of side effects.

Common side effects of naproxen include stomach pain, nausea, heartburn, or dizziness. In rare cases, more serious reactions may occur, such as gastrointestinal bleeding, severe allergic reactions, or impaired kidney function. If you notice any unusual symptoms, contact your doctor immediately.

Naproxen is an effective medication for controlling pain and inflammation, but its use requires caution, especially in people with gastric, kidney, or cardiovascular conditions. Always consult your doctor before starting treatment and inform them about any other medications you are taking.

General data about NAPROXEN AUROBINDO 250mg

  • Substance: naproxen
  • Date of last drug list: 01-06-2023
  • Commercial code: W66456002
  • Concentration: 250mg
  • Pharmaceutical form: tablets
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: APL SWIFT SERVICES (MALTA) LIMITED - MALTA
  • Holder: AUROBINDO PHARMA ROMÂNIA SRL - ROMANIA
  • Number: 11572/2019/02
  • Shelf life: 4 years

Pharmaceutical forms available for naproxen

Concentrations available for naproxen

  • 100mg/g
  • 200mg
  • 220mg
  • 250mg
  • 275mg
  • 500mg
  • 550mg

Combinations with other substances